Graeme Bell - Net Worth and Insider Trading
Graeme Bell Net Worth
The estimated net worth of Graeme Bell is at least $100,704 dollars as of 2024-12-29. Graeme Bell is the Executive VP and CFO of Anacor Pharmaceuticals Inc and owns about 10,255 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $100,704. Details can be seen in Graeme Bell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Graeme Bell has not made any transactions after 2016-06-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Graeme Bell
Graeme Bell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Graeme Bell owns 2 companies in total, including Intellia Therapeutics Inc (NTLA) , and Anacor Pharmaceuticals Inc (ANAC) .
Click here to see the complete history of Graeme Bell’s form 4 insider trades.
Insider Ownership Summary of Graeme Bell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2016-12-12 | EVP & Chief Financial Officer |
| ANAC | Anacor Pharmaceuticals Inc | 2016-06-24 | Executive VP and CFO |
Graeme Bell Latest Holdings Summary
Graeme Bell currently owns a total of 1 stock. Graeme Bell owns 10,255 shares of Anacor Pharmaceuticals Inc (ANAC) as of June 1, 2016, with a value of $100,704.
Latest Holdings of Graeme Bell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANAC | Anacor Pharmaceuticals Inc | 2016-06-01 | 10,255 | 9.82 | 100,704 |
Holding Weightings of Graeme Bell
Graeme Bell Form 4 Trading Tracker
According to the SEC Form 4 filings, Graeme Bell has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the sale of 751 shares on June 1, 2016, which brought Graeme Bell around $74,559.
Insider Trading History of Graeme Bell
- 1
Graeme Bell Trading Performance
Graeme Bell Ownership Network
Graeme Bell Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
Graeme Bell is the EVP & Chief Financial Officer of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and EVP & Chief Business Officer Derek Hicks .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, Graeme Bell made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 5,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .
In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 57,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 57,207 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
Graeme Bell Mailing Address
Above is the net worth, insider trading, and ownership report for Graeme Bell. You might contact Graeme Bell via mailing address: 1324 Waverly Road, Gladwyne Pa 19035.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
